Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001066141 | SCV001231140 | uncertain significance | Cohen syndrome | 2022-03-29 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 775 of the VPS13B protein (p.Pro775Ala). This variant is present in population databases (rs779218452, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with VPS13B-related conditions. ClinVar contains an entry for this variant (Variation ID: 859924). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Not Available"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV001066141 | SCV002784435 | uncertain significance | Cohen syndrome | 2021-12-09 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004693564 | SCV005196051 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001066141 | SCV002079511 | uncertain significance | Cohen syndrome | 2021-09-15 | no assertion criteria provided | clinical testing |